Skip to main content

This job has expired

Postdoctorate Modeling and Simulation Scientist (2 years)

Employer
F.Hoffmann-La Roche
Location
Canton of Basel-Stadt (CH)
Salary
competitive
Closing date
Sep 2, 2019

Job Details

Who we are:

At Roche, 80,000 people across 150 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity, and on seeing each other’s differences as an advantage. To innovate healthcare, Roche has ambitious plans to keep learning and growing – and is seeking people who have the same goals for themselves.

 

At Roche, we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives and we are fearless in both decision and action. And we believe that good business means a better world.

 

That is why we come to work every single day. We commit ourselves to scientific rigour, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.

 

The Position:

The Translational Modeling and Simulation Group is part of the Pharmaceutical Sciences department, focused on quantitative preclinical modeling and simulation. We are looking for an outstanding, hardworking, highly motivated individual to join our team as a Postdoctoral Research Fellow. In this role, you will integrate data from multiple sources with the goal of developing predictive mathematical, statistical and/or machine-learning models of immunogenicity in the context of drug development.

 

The Roche Postdoctoral Fellowship (RPF) program is sought at supporting excellent early-career scientists focusing on collaborative R&D projects between Roche and international academic institutions. Both internal Roche and external academic experts will act as mentors, and you will be based primarily at Roche Innovation Centre Basel, Switzerland.

 

In this position you will:

  • Develop modeling and simulation tools to support research in the area of immunogenicity
  • Integrate data from multiple sources (in-vitro, in-vivo, clinical) to generate and test hypotheses for prediction of immunogenicity incidence, management and prevention
  • Publish your findings in high-impact journals

 

Who you are:

  • A highly motivated scientist with strong experience in modeling and simulation and excellent communication skills, who enjoys working in multidisciplinary and multinational teams
  • Someone who enjoys and has experience in creative, data-driven quantitative modeling

 

Requirements:

  • PhD in mathematics, physics, engineering, statistics, biostatistics, modelling and simulation or a related discipline with no more than 4 years of work experience since graduation.
  • Strong knowledge of programming in Matlab, R, Python (other languages a plus).
  • Substantial track record of scientific publications as journal articles and conference talks
  • Fluency in written and spoken English
  • Experience in machine learning and knowledge of basic immunology would be a plus

 

When does it start? The start date of this fellowship is 1st August, or on availability. Please clearly indicate your preferred starting date on your motivation letter. All applications always need to include a CV, motivation letter and a certificate of your PhD.

Do you know what Roche stands for? Roche embraces diversity and equal opportunity in a serious way. We are committed to building a team that represents a variety of backgrounds, perspectives, and skills. The more inclusive we are, the better our work will be.

If you still have questions, then please check our FAQs and videos on careers.roche.ch/faq

 

Tags: ROiLS, ROiMK, ROiEE, ROiBI, ROiDS, ROiDIG

 

Roche is an equal opportunity employer.

Company

About Roche


Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2018 employed about 94,000 people worldwide. In 2018, Roche invested CHF 11 billion in R&D and posted sales of CHF 56.8 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.

All trademarks used or mentioned in this release are protected by law.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert